GRUPOS DE INVESTIGACIÓN

Proyectos

• Preclinical IBD: Spatial Context in Intestinal Samples (PISCIS Study).

  Investigador Principal: Rodríguez Lago, Iago

  Entidad Financiadora: (2025)

Publicaciones recientes

• Privitera G, Bezzio C, Figlioli G, D'Amico F, Mendes J, Varca S, Zingone F, Rodriguez-Lago I, Onali S, Caprioli FA, Chaparro M, Barreiro-de-Acosta M, Karmiris K, Degabli NT, Dar L, Pastorelli L, Gutiérrez A, Orlando A, Zabana Y, Saibeni S, Piovani D, Savarino EV, Pugliese D, Magro F, Danese S, Armuzzi A, . Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-line Therapy in Anti-tumor Necrosis Factor-experienced Patients With Ulcerative Colitis.. Clin Gastroenterol Hepatol. 2026 Jan;:. doi:10.1016/j.cgh.2026.01.017. Epub 2026 Jan 29. PMID:41616901.

• López-García A, Suárez Ferrer C, Maroto-Martín C, Fernandez-Prada SJ, Marquina V, Rodríguez Glez GE, Mesonero F, Lucendo AJ, Flórez-Díez P, Casanova MJ, García-Morales N, Miranda-Bautista J, Vicuña M, Font G, Benítez JM, Bernal L, Miquel O, Mínguez A, Tejedor-Tejada J, Pérez-Galindo P, Elosua A, Lastiri EA, Brunet-Mas E, Llaó J, Rodríguez-Lago I, Ferreiro-Iglesias R, López L, González-Partida I, Ortega SP, Monsalve S, González-Vivó M, Márquez-Mosquera L, Murciano Gonzalo F, Zabana Y, Barreiro-de Acosta M, . Esophageal, gastric and duodenal Crohn's disease in the biologic era: Results from a retrospective observational nationwide study of GETECCU.. Dig Liver Dis. 2026 Apr;58:464. doi:10.1016/j.dld.2025.12.034. Epub 2026 Jan 31. PMID:41622053.

• Mesonero F, Zabana Y, Fernández-Clotet A, Leo-Carnerero E, Caballol B, Núñez A, García MJ, Bertoletti F, Bastida G, Suris G, Casis B, Ferreiro-Iglesias R, Calafat M, Jiménez I, Miranda-Bautista J, Lamuela LJ, Fajardo I, Torrealba L, Nájera R, Sáiz-Chumillas RM, González-Partida I, Vicuña M, García-Morales N, Gutiérrez A, López-García A, Benítez JM, Rubín de Célix C, Tejido C, Brunet-Mas E, Hernandez-Camba A, Ferrer CS, Rodríguez-Lago I, Piqueras M, Castaño A, Ramos L, Sobrino A, Rodríguez-Grau MC, Elosua A, Montoro-Huguet MA, Baltar R, Huguet JM, Hermida B, Caballero-Mateos A, Sánchez-Guillén L, Bouhmidi A, Pajares R, Baston-Rey I, López-Sanromán A, Albillos A, Barreiro-de Acosta M. Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU.. Ther Adv Gastroenterol. 2026 ;19:17562848261422373. doi:10.1177/17562848261422373. Epub 2026 Feb 18. pmc:PMC12925033. PMID:41732330.

• Boix-Amorós A, Bu K, Blank RB, Cantor A, Gutiérrez-Casbas A, Rodríguez-Lago I, Marin-Jimenez I, Sanz J, Masmitja JG, Trujillo E, Muñoz MC, Vivar MLG, Carrillo M, Hernández MVH, Calvet X, Salaet MA, Romero MI, García AB, Pérez S, Llorente JFG, Gonzalez-Lama Y, Argumánez CM, Plaza Z, Domínguez M, Cañete JD, Diaz-Gonzalez JF, Scher JU, Clemente JC. Microbial signatures in psoriatic arthritis distinguish disease phenotypes and newly diagnosed inflammatory bowel disease independent of faecal calprotectin.. Ann Rheum Dis. 2026 May;85:806. doi:10.1016/j.ard.2026.01.018. Epub 2026 Feb 28. PMID:41763967.

• Rodríguez-Lago I, Peinado-Fabregat JI, Guigini M, Cerezales M, Ibáñez F, Crespo C, Barreiro-de Acosta M. Cost-Effectiveness Analysis of Sequential Treatment Strategies for Moderate to Severe Crohn's Disease in Spain: Where Should Biosimilar Ustekinumab Be Positioned?. Pharmacoecon Open. 2026 May;10:557. doi:10.1007/s41669-026-00642-1. Epub 2026 Mar 09. pmc:PMC13194847. PMID:41803589.

• Ferreiro-Iglesias R, Hernández-Camba A, Valdivia A, Rodríguez-Lago I, Zabana Y, Barreiro-de Acosta M, . Vaccination recommendations and adherence in inflammatory bowel disease: A physician-patient discordance study.. Gastroenterol Hepatol. 2026 Mar;:502714. doi:10.1016/j.gastrohep.2026.502714. Epub 2026 Mar 02. PMID:41780635.